Individual cancers rely on distinct essential genes for their survival. The Cancer Dependency Map (DepMap) is an ongoing project to uncover gene dependency in hundreds of cancer cell lines. DepMap is a powerful drug discovery tool, but can be challenging to use without professional bioinformatics assistance. We combined CRISPR and shRNA screening data from DepMap and built a non-programmer-friendly browser (https://labsyspharm.shinyapps.io/depmap) that reports, for each gene, the growth reduction that can be expected on loss of a gene or inhibition of its action (efficacy) and the selectivity of this effect across cell lines. Cluster analysis revealed proteins that work together in pathways or complexes. This tool can be used to 1) predict the efficacy and selectivity of candidate drugs; 2) identify targets for highly selective drugs; 3) identify maximally sensitive cell lines for testing a drug; 4) target hop, i.e., navigate from an undruggable protein with the desired selectively profile, such as an activated oncogene, to more druggable targets with a similar profile; and 5) identify novel pathways needed for cancer cell growth and survival.
Introduction
Cancer is a disease of the genome. Hundreds, if not thousands, of driver mutations drive cancer in different patients (Bailey et al., 2018) , and large collaborative efforts such as the Cancer Genome Atlas Program (TCGA) have helped discover them (The Cancer Genome Atlas Research Network, 2019) . Targeted therapies, also called precision medicine, aim to cure cancer by selectively killing cancer cells with a specific genotype and spectrum of driver mutations (Friedman et al., 2015) . The underlying hypothesis is that cancers depend on essential genes that are not the same for all cancers, and that these conditionally essential genes constitute a druggable dependency -an "Achilles' heel" -that can be exploited to develop targeted drugs with minimal toxicity to normal tissues. To achieve this goal, it is important to identify conditionally essential genes for all cancers. It is also important to group conditionally essential genes into related sets, to maximize the chance of finding a druggable target within the set, such as a kinase or other enzyme.
The concept of essential vs non-essential genes arose largely from genetic research in model organisms. Traditionally, it was considered a binary distinction that held across any genotype. However, loss of a given gene can decrease cell growth without killing the cell, so it is more realistic to assign a numerical value to the degree of essentiality, i.e., the extent to which loss of a gene, or inhibition of its product, influences fitness. In cancer, this value may depend on the genotype, transcriptome, and lineage of the cell. In principle, genes that are only essential in a few cell types might make better drug targets, since inhibiting their function is less likely to cause toxicity in non-cancer tissues. For example, the epidermal growth factor receptor is strongly required in certain cancer cells, but not in normal bone marrow stem cells, making it potentially a good target (Wang et al., 2006) .
The Cancer Dependency Map project (DepMap) is an ongoing project to identify essential genes across hundreds of cancer cell lines using genome-wide CRISPR and shRNA screens (Tsherniak et al., 2017; Behan et al., 2019) . It has already been used successfully to discover genetic vulnerabilities of cancer cells (Sandoval et al., 2018; Wang et al., 2019b) .
These data represent a gold mine of useful information for biologists and drug developers, but can be challenging for non-bioinformaticians to manipulate and interpret.
The DepMap portal website (https://depmap.org/portal) provides a range of information for each gene, cell lines and lineage dependent on the gene, and co-dependent genes (i.e., other genes whose dependency scores are highly correlated with the gene) as well as basal transcriptome, copy numbers, and mutations of the gene. However, there are no native tools available in DepMap for systematically comparing one gene with all other genes to determine the range of options available for attacking a particular tumor type. We set out to develop a web tool to enable researchers to rapidly determine the essentiality and selectivity of a given gene across cell lines, and to find other genes with similar essentiality profiles.
To explore gene essentiality in the DepMap data we first compared two datasets based on CRISPR and shRNA screens. We found that the degree of concordance was moderate, and that it was useful to combine the data into a unified "perturbation score". Other recent studies also showed that similar approaches are useful (Gilvary et al., 2019; Wang et al., 2019a) . For each gene, this score reports the degree to which loss of the gene reduces cell growth in sensitive lines ("efficacy"), and the degree to which its essentiality varies across lines ("selectivity"). We then visualized all genes on a 2D plot, and defined an essential subset using an arbitrary threshold on efficacy. Next, we clustered perturbation scores of essential genes to discover shared essentiality. Many clusters represent complexes or biological pathways, as previously reported . We made the analysis accessible as a simple interactive web-tool (https://labsyspharm.shinyapps.io/depmap) to help others identify target genes for anti-cancer drugs, and to discover the mechanistic basis of essentiality in specific cell types.
Results
shinyDepMap: an interactive web tool to explore essentiality of genes shinyDepMap was made utilizing the shiny package of the R language (Chang et al., 2019) . It consists of two services, "Essentiality-Selectivity (all genes)" and "Functional clusters (essential genes only)". shinyDepMap is a dashboard-style website that is split into three components when opened in a web browser: menu bar, input sidebar, and output (Fig. 1A) .
The services can be opened from the menu bar. This tool can be accessed in two ways, by querying our web site or by downloading the code and pre-processed data from the code repository (https://github.com/kenichi-shimada/shinyDepMap) and run it on a local computer.
The first two sources will be maintained and updated by the authors when the original data in the DepMap project are updated. The last method comes with the executable R with all the packages installed, and therefore it is easiest i. Efficacy-Selectivity (all genes)
ii. Functional clusters (essential genes only)
Show their efficacy/selectivity (9) Show their locations in t-SNE plot (10) Show perturbation scores stratified by lineage (5) Input a partial or full gene name (1) Show their efficacy/selectivity (3) List genes whose names match the input (4) Select an essential gene (6) Change the cluster size (7) Perturbation scores stratified by lineage (12) Show correlation within the same cluster (13) List genes in the cluster together with the selected gene (11) Click on another cluster (11) Change the color code in the plots (8) i. Efficacy-Selectivity (all genes) ii. Functional clusters (essential genes)
Pick one of the genes (2) Show correlation among essential genes, stratified by cluster (14 The perturbational score profiles of a selected gene stratified by lineage.
ii. Functional clusters. 6. Gene symbol query. 7. Cluster size (three levels). 8. Color codes of plots. 9. Efficacy-selectivity of essential genes. 10. example t-SNE plot of the perturbation score profiles. 11. Gene lists of the cluster. 12. The perturbations score profiles of a selected gene (the same information as 5). 13-14. Spearman correlation coefficients between the genes within the same cluster (13) or across all the clusters (14).
Computation of a unified 'perturbation score'
The DepMap website (https://depmap.org/) provides two separate pre-processed genome-wide genetic perturbation data in hundreds of cell lines, in which shRNA and CRISPR efficacy data were normalized using DEMETER2 and CERES algorithms, respectively (Meyers et al., 2017; McFarland et al., 2018) . In both, genes with more negative values are considered essential in the corresponding cells. Since the algorithms take 'off-targets' into consideration, the normalized CRISPR and shRNA data should give similar scores. To assess this consistency, we compared CRIPSR and shRNA scores in the 4,846,055 equivalent conditions, where the same genes were targeted in the same cell lines ( Fig. 2A ). We observed a generally high degree of consistency between the two technologies, with some biases. CRISPR tends to detect weak to moderate effects of gene deletion more sensitively while shRNA tends to detect moderate to strong effects ( Fig. S1A,B ). While CRISPR is claimed to be much less susceptible to off-target effects (Smith et al., 2017) , it was most informative to combine CRISPR and shRNA data together considering their different dynamic ranges. We developed a new gene dependency metric, termed "perturbation score", which is equivalent to a primary principal component of the two efficacy measures (Fig. 2B ). The resulting data consist of the perturbation scores of 15,847 genes in 423 cell lines, in which both screenings were performed (Supplemental Data 1).
We next compared the median perturbation scores across cell lines for each gene with the median CRISPR and shRNA efficacy. The perturbation scores were much more correlated with CRISPR efficacy than with shRNA efficacy (Fig. 2C, Fig. S1C,D) . While the perturbation score and CRISPR efficacy were highly correlated, genes involved in certain biological functions, such as transcription, pre-mRNA processing, translation, chaperonin, and protein Figure 2) . Comparison between CRISPR, shRNA, and the perturbation score A. Search for genes responsive only to CRISPR or shRNA. Red boxes A and B correspond to genes whose suppression by CRISPR or shRNA were found effective to suppress cell growth respectively, but not by the other technology. SNAPC4 and ACTG2 ( Fig. 2A) were examples overrepresented in each box.
B. Overrepresentation of genes in boxes
A and B in A. Genes overrepresented in each box were assessed by empirical cumulative distrubtion function of p values computed by Fisher's exact test. C. Median efficacy scores using shRNA efficacy and the perturbation score.
Median value across the cell lines is plotted for each gene. Red points correspond to the gene whose median shRNA efficacy is lower than the linear regression by 0.1 or more. D. The Spearman correlaion coefficients between median efficacy scores for the three measures, shRNA, CRIPSR, and the perturbation score. E. Comparison of the Spearman correlation coefficients among 2,492 essential genes, generated using three efficacy measures. Bottom left is the scatter plots, and top right is the corresponding Spearman correlation coefficients between the two measures.
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C degradation, were found to be more essential overall according to the perturbation score over CRISPR efficacy. shRNA-induced knockdown of these genes had larger effects than knockdown of many other genes, for unknown reasons (Fig. 2D ). We identified 2,492 essential genes in later analysis and assessed their functional similarity based on the Spearman correlation of their dependency profiles across all the cell lines. The functional similarities between the essential genes computed from the CRISPR or shRNA efficacy alone are not correlated (Fig. S1E) . The functional similarities from the perturbation score and the CRISPR efficacy have good agreement, but some gene pairs were found more strongly positively or negatively correlated using the perturbation score while little to no correlations using the CRISPR efficacy ( Fig.2E, Fig. S1E ). UTP14A, a gene involved in ribosome biogenesis, was one of such genes. The stronger correlations using the perturbation score can be due to the shRNA data since these genes were scored more essential using shRNA than using CRISPR ( Fig. 2F) . In later analyses, UTP14A was found clustered together with other essential genes involved in ribosomal biogenesis, however, UTP14A and most of these genes were not significantly correlated using CRISPR (Fig. 2G ). In this case, the stronger positive correlations only seen using the perturbation score seems to reflect the reality rather than they are artifacts of the analysis. Thus, we concluded that the perturbation score is as good as CRISPR, and for certain genes, represents a better efficacy measure than CRISPR or shRNA alone. We decided to use the perturbation score for the rest of the analysis.
Identification of essential genes
We next asked which genes were essential. Cancers take various phenotypes and they depend on different essential genes. A gene can be strongly essential in a few cell lines, while most cell lines do not need it for survival. Parametric description of distributions, such as mean or standard deviation, is not an appropriate way to capture such cases. We chose nonparametric quantiles, namely, the perturbation score of 10 th most sensitive cell line for each 
Overrepresented pathways Gene
Stress response DNA repair gene as efficacy. The distribution of the efficacy was asymmetric and had a heavy lower tail when the normal distribution was fit, which likely correspond to essential genes in sensitive cell lines. We identified 2,492 essential genes whose efficacy was < -0.560, which is significantly outside of the normal distribution (p < 1e-3) (Fig. 3A ). The majority of included genes were robustly identified as essential irrespective of definitions of efficacy (i.e., the perturbation scores of 20 th or 42 nd sensitive cell lines that roughly correspond to 5 th and 10 th percentiles, instead of 10 th sensitive cell line that corresponds to 2.5 th percentiles; Fig. S2A-C) . 
Computation of cell line selectivity
Next, we assessed the selectivity of each gene. The selectivity is an important measure for potential good drug targets for synthetic lethality; drugs targeting generally essential genes may be toxic not only to cancers but can harm other normal cells. Like the efficacy, we nonparametrically defined the selectivity. We first looked at the difference between the perturbation scores of the 10 th most and least sensitive cell liens and found that the difference is in a strong linear relationship for about 80% of genes. In other words, the dispersion of the distributions, assessed by the difference is determined by the efficacy (the perturbation score of the 10 th most sensitive cells) for these genes. The more essential a gene is, the larger the dispersion is (Fig. 3B, Fig. S2D,E ). Taking this relationship into consideration, we defined the selectivity as = ( − ′)/( * ′), where s is the selectivity, and d and d' are the measured and estimated dispersions, and k=3.772 is a coefficient such that s > 1 is considered significantly selective (p < 1e-3), when the normality is assumed for the distribution of the selectivity. With this definition, we found 1,309 genes selective, 735 of which were also essential (Supplemental Data 2).
By comparing the efficacy and the selectivity, we found that the genes with high essentiality (i.e., large negative efficacy) tend to be less selective, but selectively essential genes tend to be moderate essential (Fig. 3D) . Gene set enrichment analysis of 6,551 existing pathways in Molecular Signature Database (v7.0) revealed that essential and selective genes were characterized by chromatin regulation, for example, essential (but not selective) genes by nuclear metabolism and translation, selective (but not so essential) genes by regulation of kinase activity and tissue development (Fig. 3E, Fig. S3 Figure  3) . Pathway enrichment against essential and selective genes A. Definition of overlap index (OI) of two pathways, which describes how many genes are overlapped between two pathways. B. Overlap index of pathways that are significantly overrepresented in 1) essential and selective genes, essential genes and selective pathways.
Cluster analysis of the perturbation scores revealed functional modules
The perturbation score across cell lines of a given gene carries information about the cellular context that makes the cell dependent on the activity of that gene. Cluster analysis of these data should reveal pathways that connect genes into functional units. This type ofanalysis has several benefits. It may be easier to relate the essentiality of pathways to cancer genotypes than to interpret essentiality for individual genes, and pathway analysis can help identify druggable vulnerabilities at the pathway level that might be missed by single gene analysis. We clustered genes based on the similarity of the perturbation scores across 423 cell lines. For this, we utilized a customized clustering algorithm, termed ensemble clustering with hierarchy over DBSCAN on t-SNE with Spearman distance matrix (ECHODOTS), which extends our previous algorithm (Shimada and Mitchison, 2019) (Fig. 4A ). As the name indicates, ECHODOTS relies on t-distributed stochastic neighbor embedding (t-SNE) and subsequently clustering of the coordinates given by t-SNE utilizing density based spatial clustering and noise (DBSCAN) (Maaten and Hinton, 2008; Maaten, 2014; Ester et al., 1996) . t-SNE is a non-linear dimensionality reduction algorithm that has become particularly popular in biology to visualize high-dimensional single cell data in 2D. The algorithm compares pairwise distances between all data points both at the original high dimension and at low (two) dimension, and attempts to minimize the difference between the two. t-SNE outperforms many other dimensionality reduction algorithms at displaying data points in 2D in a non-overlapping manner while retaining the local structure of the original data. The resulting low-dimensional plot gathers similar points and isolates dissimilar points, which is a perfect preprocessing of data to be used for certain cluster analyses. While t-SNE is powerful, it has its own drawbacks. Repeated runs on the same input data produce distinct results due to the non-convexity of the algorithm. This variation between runs may be acceptable for a data visualization purpose as long as they are similar, but robustness can be a serious issue for clustering purposes. To make the cluster analysis more robust, we ran t-SNE and subsequent DBSCAN 200 times and performed ensemble clustering to find genes that are consistently assigned into the same cluster across all runs. In clustering, DBSCAN algorithm takes input data, i.e., t-SNE coordinates, from which distances between any two data points (genes) are calculated, and a neighborhood threshold e. It assigns two genes into the same cluster when the distance between the genes is smaller than e. When e is small, clusters get small and tight. When e is large, clusters get big and loose. When e is too large, many data points are connected to become one large cluster (Fig.4B) . To avoid overconnection, we set a lower bound for e (or an upper bound for d) such that the size of the 1 st and 2 nd largest clusters ≤ b (b = 2.26 in our case) (Fig. 4C) . The tighter clusters found with smaller e are expected to be merged into bigger clusters found with larger e. We chose three reasonable values of e, and constructed a hierarchy between the three sets of clusters. We discovered 604 small, 411 medium, and 203 large clusters using ECHODOTS (Fig. 4D , Supplemental Data 3). Some clusters contain as many as 31 genes (small cluster) or 292 genes (large cluster). Many of the clusters has only as few as ≤ 5 genes (83% of the small clusters, 49% of the large clusters). The median cluster size is 6, 4, and 3 genes for small, medium, or large clusters, respectively. Median efficacy and selectivity of the clusters vary widely (Fig. 4F,G) .
ECHODOTS clusters essential genes when they are so strongly correlated with each other that they are always found as neighbors to each other on t-SNE map. However, this does not mean that every pair of genes in the same cluster is strongly positively correlated. For a gene to be in a cluster with other genes, the gene is only required to be the neighbor of at least one of them. One should always check the Spearman correlation coefficients to interpret the data. An example of this is cluster L137, which consists of four highly selective essential genes, CUL3, KCTD10, KEAP1, and TSC2 (Fig. 4H ). Keap1 and KCTD10 proteins serve as adaptor proteins for Cul3-based E3 ligase. They are each known to bind to the same site of Cul3 to form E3 ligases, but they degrade distinct target proteins (Nrf2 and RhoB, respectively) (Cullinan et al., 2004; Kovačević et al., 2018) . Since they bind to the same site on Cul3, they should not bind to Cul3 simultaneously. Indeed, the Spearman correlation coefficients between the four genes revealed that CUL3 is positively correlated with KEAP1 and KCTD10, but KEAP1 is not correlated with KCTD10.
Perhaps more intriguing are clusters that appear to show a connection between specific cellular processes and genes not otherwise known to be involved in that process. One example is cluster L33 (Fig. 4I ). This consists of three small clusters. Cluster S72 comprises several genes known to protect cancer cells from apoptosis, such as BCL2L1, CFLAR, and FADD. Clusters S119 and S354 contain genes involved in NF-kB signaling pathway, such as RELA, NFKB2, MAP3K7, and TRAF2. While there is some evidence of a connection between Bcl-xL and NF-kB (Glasgow et al., 2001; Khoshnan et al., 2000) , this has not received much attention in cancer research. A network of the correlated genes of this cluster suggests that these genes are particularly well connected through MAP3K7 (encoding TAK1), CFLAR (encoding c-FLIP), and an uncharacterized transcription factor ZNF638. Another example is the cluster L78, which consists of two small clusters ( Fig. 4J ). Cluster S106 contains an antioxidant enzyme and a selenoprotein GPX4, and the genes involved in selenoprotein synthesis (SEPHS2, SEPSECS, PSTK, EFFSEC) (Squires and Berry, 2008) . S493 contains another selenoprotein TXNRD1 and its substrate TXNDC17 (Espinosa and Arnér, 2018) , which are strongly correlated with four selenoprotein synthesis genes. This cluster likely represents gene that modulate ferroptosis (Abdalkader et al., 2018; Ingold et al., 2018) .
Discussion
Traditional cytotoxic drugs tend to be efficacious, in the sense of killing most cell lines, but not very selective. This translates into treatments that are broad-spectrum but often highly toxic. The goal of precision medicine is to achieve "synthetic lethality" at the cellular level, and thus greatly improve efficacy and selectivity at the organismal level, at a cost of narrower applicability. Major challenges to achieve precision medicine in cancer research include understanding the landscape of essential genes in different cancers and predicting the efficacy and selectivity of new drugs. The DepMap is a powerful repository of data relevant to precision medicine, but difficult for scientists without bioinformatics training to browse. We found that the CRISPR and shRNA genome-wide screening datasets in DepMap were sufficiently concordant that we were able to combine them to generate the 'perturbation scores' that were more reliable than data from either one alone. Looking at the 10 th most and least sensitive cell lines, we computed 'efficacy' and 'selectivity' parameters for each gene. Our tool, shinyDepMap, allows the user to rapidly determine the efficacy and selectivity of a gene of interest, and also to find highly selective genes that may offer good targets for precision medicine.
Our cluster analysis of the perturbation scores identified genes that are linked in complexes and pathways as previously reported . Our analysis complements published work in the area of complex and pathway annotation, in part because we were able to combine both DepMap datasets. We provide cluster information in browsable form in shinyDepMap, including a tool that allows clusters to be made more or less tight. An important use of this tool is "target hopping", i.e., moving from one drug target to another while keeping the selectivity profile similar (Schenone et al., 2013) . One goal in target hopping is to move away from a competitor's target. Another is to identify druggable targets with similar selectively profiles to genes of interest that are not conventionally druggable. For example, suppose a chemist wanted to target KRAS dependent cancers. KRAS is in cluster L84 with two much more druggable kinase proteins, RAF1 and MAPK1, suggesting that these may be alternative targets based on DepMap data.
In this paper, we only touched on a few findings from our analysis due to limitations of space. shinyDepMap should open up many opportunities for researchers to identify potential druggable cancer targets. However, the interpretation of these data requires much caution.
The data in DepMap describes gene requirements for cells growing in monolayer culture in nutrient rich media, a very different environment from the environment of a solid tumor within a patient. Lack of a physiological microenvironment, and in particular the lack of information about the responses of the immune system, may limit clinical translation of gene dependencies. Moreover, the selectivity parameter we developed here is based only on the information on the cell lines included in DepMap, most of which are equivalent to aggressive and malignant cancers and none of which are wild-type non-cancerous. Provided these limitations are kept in mind, DepMap is a powerful resource, and we hope the shinyDepMap tool increases access to it. 
Figure legends

B.
The perturbation score profiles of the same four genes as A.
C. Comparison of median CRISPR efficacy and median perturbation score of 15,847 genes.
378 genes in red are the genes whose perturbation scores are lower than CRISPR efficacy by 0.1 or more.
D.
Prefix of gene symbols that are overrepresented in the 378 genes in C. -logP is negative log transformation of p-value computed by Fisher's exact test.
E. Spearman correlation coefficients between 2,492 essential genes. Correlation was calculated based on the CRISPR efficacy and perturbation scores, respectively. Correlation coefficients of the 274 gene pairs in red were greater by 0.4 ore more when calculated based on perturbation scores than calculated based on CRISPR efficacy. Top five genes frequently seen are listed.
F. CRISPR and shRNA efficacy targeting UTP14A.
G. Spearman correlation coefficients between UTP14A and the other essential genes. Genes clustered with UTP14A in the later analysis were highlighted in red.
See also Fig. S1 . C. Comparison between shRNA efficacy and combined perturbation score. Median across the cell lines is plotted for each gene. Red points correspond to the gene whose median shRNA efficacy is lower than the linear regression by 0.1 or more.
D. Spearman correlation coefficients between median efficacy scores for the three measures, shRNA, CRIPSR, and combined perturbation score.
E. Comparison of the Spearman correlation coefficients among 2,492 essential genes, generated using three efficacy measures. The corresponding Spearman correlation coefficients are also shown. 
